Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Ironwood Pharmaceuticals Inc IRWD

Healthcare Biotechnology
Ironwood Pharmaceuticals, Inc. is a gastrointestinal (GI) healthcare company engaged in advancing the treatment of GI diseases and redefining the standard of care for GI patients. It is engaged in the development of LINZESS (linaclotide) for adults with irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC). Linaclotide is also approved for the treatment of... see more

Recent & Breaking News (NDAQ:IRWD)

Generic Drugs Stock Performance Review -- Ironwood Pharma, Medicines Co., Supernus Pharma, and Pacira Pharma

PR Newswire June 12, 2017

Ironwood Pharmaceuticals to Present at the Goldman Sachs 38th Annual Global Healthcare Conference

Business Wire June 8, 2017

Ironwood Pharmaceuticals to Present at the Jefferies Healthcare Conference

Business Wire June 1, 2017

Ironwood Pharmaceuticals to Present at the Bank of America Merrill Lynch Healthcare Conference

Business Wire May 10, 2017

Ironwood Pharmaceuticals Presents Data Further Elucidating Linaclotide’s Effect on Pain at Digestive Disease Week® 2017

Business Wire May 9, 2017

Ironwood Pharmaceuticals Provides First Quarter 2017 Investor Update

Business Wire May 8, 2017

Investor Network: Ironwood Pharmaceuticals, Inc. to Host Earnings Call

Accesswire May 8, 2017

Ironwood Pharmaceuticals to Present New Data for Linaclotide, Linaclotide Delayed Release and IW-1701 at Digestive Disease Week® 2017

Business Wire May 1, 2017

How These Generic Drugs Stocks are Faring? -- Medicines Co., Ironwood Pharma, Pacira Pharma, and Supernus Pharma

PR Newswire May 1, 2017

Ironwood Pharmaceuticals to Host First Quarter 2017 Investor Update Call

Business Wire April 24, 2017

Allergan and Ironwood Launch Campaign Designed to Empower the Nearly 64 Million Americans Estimated to Suffer from IBS and CIC to Talk About Bowel Health(1-5)

PR Newswire April 13, 2017

Ironwood Pharmaceuticals Appoints Dr. Christopher Wright as Senior Vice President of Global Development and Chief Development Officer

Business Wire April 6, 2017

Research Reports Initiation on Generic Drugs Stocks -- Medicines, Ironwood Pharma, Pacira Pharma, and Supernus Pharma

PR Newswire March 28, 2017

Ironwood Pharmaceuticals to Present at Barclays Global Healthcare Conference

Business Wire March 10, 2017

Ironwood Pharmaceuticals Showcases Progress Delivering Innovative Medicines to Patients and Building a Top-Performing Commercial Biotech at R&D Day 2017

Business Wire March 9, 2017

Ironwood Pharmaceuticals to Present at Cowen and Company 37th Annual Health Care Conference

Business Wire February 28, 2017

Ironwood Pharmaceuticals to Host R&D Day on March 9, 2017

Business Wire February 23, 2017

Ironwood Pharmaceuticals Provides Fourth Quarter and Full Year 2016 Investor Update

Business Wire February 21, 2017

Ironwood Pharmaceuticals to Host Fourth Quarter and Full-Year 2016 Investor Update Call

Business Wire February 7, 2017

Generic Drugs Stocks on Investors' Radar -- Ironwood Pharma, Medicines, Rigel Pharma, and Lannett

PR Newswire January 30, 2017